Merieux Equity Partners Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Merieux Equity Partners has acquired 2 companies. It has also invested in 2 others.

Merieux Equity Partners’ most common sectors for investment arelife science (48%) and medical products (20%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (34%) and growth capital (34%). In total, Merieux Equity Partners has invested in 1 US state and 9 different countries.

In the last 3 years, Merieux Equity Partners has exited 3 companies. The Firm’s most common exit type is trade sale (40%).

Sign-up to view Merieux Equity Partners’ full profile and discover more large growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity26
    • M&A Buy Activity21
    • M&A Sell Activity5
  • Total Sectors Invested 7
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 9
  • M&A Advisors 4

Merieux Equity Partners

3, Rue Marcel Gabriel Rivière ,
Lyon, 69002
France
+33 4 78 87 37 00
www.merieux-developpement.com
info@merieux-partners.com

Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.


Investment Criteria

Sectors of Interest: Chemicals, Healthcare Services, Life Science, Medical Products

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Nordic, Middle East

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 20 80
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (1.4/yr) # 14 3 1 1 1 1 21
Sell (0.6/yr) # 2 - 1 - 2 - 5
  26

Most Recent M&A

Company Date Value Type
Deepull 2025-04-29 - Growth Capital
Barcelona, Spain · www.deepull.com
GTP Bioways SAS 2024-07-03 - Trade Sale
Toulouse , France · www.gtp-bioways.com
InnoSyn B.V. 2024-02-05 - Buyout (LBO, MBO, MBI)
Geleen, Netherlands · www.innosyn.com
Mabtech AB 2024-01-09 - Secondary Sale
Nacka Strand, Sweden · www.mabtech.com
Piercan 2023-03-21 - Buyout (LBO, MBO, MBI)
San Marcos, California · www.piercanusa.com
Janvier Labs 2022-07-19 - Growth Capital
Le Genest-Saint-Isle, France · www.janvier-labs.com
Doc Generici Srl 2022-06-30 - Secondary Sale
Milan, Italy · www.docgenerici.it
Dental Monitoring SAS 2021-10-21 - Secondary Buyout
Paris, France · www.dentalmonitoring.com
DomusVi SAS 2021-07-02 - Growth Capital
Suresnes, France · www.domusvi.com
Plantex 2021-01-28 - Buyout (LBO, MBO, MBI)
Saint-Michel-sur-Orge, France · www.plantex.fr
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
SERB S.a.r.l. 2017-06-09 Wellstat Therapeutics - Vistogard and Xuriden 2023-07-13 2
Luxembourg, Luxembourg · wwwserb.com Rockville, Maryland
Seqens SAS 2016-03-21 Wavelength Pharmaceuticals 2021-08-26 3
Ecully, France · www.seqens.com Petah Tikva, Israel · www.wavelengthpharma.com
SERB S.a.r.l. 2017-06-09 BTG Specialty Pharmaceuticals 2020-12-01 1
Luxembourg, Luxembourg · wwwserb.com Gladwyne, Pennsylvania · www.btgsp.com
CEVA Sante Animale SA 2007-04-25 Thundershirt LLC 2019-07-30 4
Libourne, France · www.ceva.com Durham, North Carolina · www.thundershirt.com
Seqens SAS 2016-03-21 Chemoxy International Ltd. 2017-07-22 2
Ecully, France · www.seqens.com Middlesbrough, United Kingdom · www.chemoxy.com
CEVA Sante Animale SA 2007-04-25 Sogeval SA 2013-12-20 3
Libourne, France · www.ceva.com Laval, France · www.sogeval.fr
CEVA Sante Animale SA 2007-04-25 Vet Brands International, Inc. 2007-07-11 2
Libourne, France · www.ceva.com Miramar, Florida · www.vetbrands.com

M&A by Sector

Sector Current # Value All-time # Value
Life Science 8 (47%) - 10 (48%) -
Medical Products 3 (18%) - 4 (19%) -
Chemicals 2 (12%) - 2 (10%) -
Healthcare Services 1 (6%) - 2 (10%) -
Consumer Services 1 (6%) - 1 (5%) -
Distribution 1 (6%) - 1 (5%) -
Manufacturing 1 (6%) - 1 (5%) -
Total 17 - 21 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
France 11 (65%) - 12 (57%) -
United States 1 (6%) - 2 (10%) -
  California 1 (6%) - 2 (10%) -
Spain 1 (6%) - 1 (5%) -
Belgium 1 (6%) - 1 (5%) -
Luxembourg 1 (6%) - 1 (5%) -
Netherlands 1 (6%) - 1 (5%) -
Switzerland 1 (6%) - 1 (5%) -
Italy - - 1 (5%) -
Sweden - - 1 (5%) -
Total 17 - 21 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 5 (29%) - 7 (33%) -
Growth Capital 6 (35%) - 7 (33%) -
Secondary Buyout 5 (29%) - 6 (29%) -
Stake Purchase 1 (6%) - 1 (5%) -
Total 17 - 21 -

Exits by Deal Type

Type Total # Value
Secondary Sale 2 (40%) -
Trade Sale - Public Company 2 (40%) -
Trade Sale 1 (20%) -
Total 5 -

Top M&A Advisors

Financial Deals
Barclays Investment Bank
1
BNP Paribas CIB
1
Legal Deals
White & Case
1
Gattai, Minoli, Agostinelli & Partners
1

M&A Connections

Deals
Acquired from
Investor(s)
29%
6 (29%)
Strategic(s)
5%
1 (5%)
Exited to
Investor(s)
40%
2 (40%)
Strategic(s)
40%
2 (40%)

FAQ

When was Merieux Equity Partners founded?

Merieux Equity Partners was founded in 2009.

What type of investor is Merieux Equity Partners?

Merieux Equity Partners is a growth capital firm.

Where is Merieux Equity Partners headquartered?

Merieux Equity Partners is headquartered in Lyon, France.

How much capital does Merieux Equity Partners have under management?

Merieux Equity Partners has 1.3B EUR under management.

Try Mergr Free — See This and 215,174+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 209K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.